Subscribe to RSS
DOI: 10.1055/s-2005-864820
Synthesis of 6,6-Difluorocyclopropa[b]furo[2,3-c]pyrrole and 7-Fluorofuro[3,2-c]pyridine Derivatives via 1,5-Electrocyclization of Carbene-Derived Azomethine Ylides
Publication History
Publication Date:
23 March 2005 (online)
![](https://www.thieme-connect.de/media/synlett/200506/lookinside/thumbnails/10.1055-s-2005-864820-1.jpg)
Abstract
Reaction of N-(5-R-furan-2-ylmethylidene)anilines with difluorocarbene, generated in CF2Br2/Pb*/Bu4NBr/ultrasound system proceeds via 1,5-electrocyclization of intermediate azomethine ylides to give 6,6-difluorocyclopropa[b]furo[2,3-c]pyrrol-4(5H)-one or/and 4,4,6,6-tetrafluorocyclopropa[b]furo[2,3-c]pyrrole derivatives. Thermolysis of these compounds under solvent-free conditions gives rise to 2,5-disubstituted 7-fluoro-4,5-dihydrofuro[3,2-c]pyridine-4(5H)-ones in high yields.
Key words
ylides - carbenes - cylizations - fused heterocycles
-
1a
Yue WS.Li JJ. Org. Lett. 2002, 2201 -
1b
Soldatenkov AT.Polyanskii KB.Soldatova SA. Chem. Heterocycl. Compd. 2002, 38: 368 -
1c
New JS.Christopher WL.Yevich JP.Butler R.Schlemmer RF.Van der Maelen CP.Cipollina JA. J. Med. Chem. 1989, 32: 1147 -
1d
Maffraund JP.Eloy F. Eur. J. Med. Chem. Chim. Ther. 1974, 483 -
1e
Podesta M.Aubert D.Furand JC. Eur. J. Med. Chem. Chim. Ther. 1974, 487 -
1f
Makikado T. inventors; Japanese Patent 7015985. ; Chem. Abstr. 1970, 73, 77220 -
1g
Makikado T. inventors; Japanese Patent 7033655. ; Chem. Abstr. 1971, 74, 76400 -
1h
Simpson WRJ. inventors; Ger. Offen 2350387. ; Chem. Abstr. 1974, 81, 13555 - 1i inventors; Centre d’Etudes de l’Industrie Pharmaceutique. Ger. Offen 2404308. ; Chem. Abstr. 1974, 81, 316131
-
2a
Lhommet G.Sliwa H.Maitte P. Bull. Soc. Chim. Fr. 1972, 1442 -
2b
Bisagni E.Civier A.Marquet J.-P. J. Heterocycl. Chem. 1975, 12: 461 -
2c
Abramovitch RA.Deep A.Kishore D.Mpango GBW. Gazz. Chim. Ital. 1988, 118: 167 -
2d
Hörlein G.Kübel B.Studeneer A.Salbeck A. Liebigs Ann. Chem. 1979, 371 -
2e
Shiotani S.Morita H.Ishida T.Iu Y. J. Heterocycl. Chem. 1988, 25: 1205 -
2f
Moron J.Nguyen CH.Bisagni E. J. Chem. Soc., Perkin Trans. 1 1983, 225 -
3a
Eloy F.Deryckere A. Bull. Soc. Chim. Fr. 1971, 1442 -
3b
Eloy F.Deryckere A. J. Heterocycl. Chem. 1971, 8: 57 -
3c
Bouzart JD.Bisagni E. Bull. Soc. Chim. Fr. 1971, 1727 -
3d
Molina P.Fresneda PM.Hurtado F. Synthesis 1987, 45 -
3e
Krutosikova A.Dandarova M.Chilova J.Vegh D. Monatsh. Chem. 1992, 123: 807 -
3f
Korenova A.Krutosikova A.Kovac J.Celec S. Coll. Czech. Chem. Commun. 1987, 52: 192 -
3g
Bobosik V.Krutosikova A.Jordis U. Monatsh. Chem. 1995, 126: 747 -
4a
Khlebnikov AF.Novikov MS.Kostikov RR. Russ. Chem. J. 1999, 43: 70 -
4b
Novikov MS.Khlebnikov AF.Sidorina ES.Kostikov RR. J. Fluorine Chem. 1998, 90: 117 -
4c
Novikov MS.Khlebnikov AF.Krebs A.Kostikov RR. Eur. J. Org. Chem. 1998, 133 -
4d
Novikov MS.Khlebnikov AF.Sidorina ES.Kostikov RR. J. Chem. Soc., Perkin Trans. 1 2000, 231 -
4e
Novikov MS.Khlebnikov AF.Besedina OV.Kostikov RR. Tetrahedron Lett. 2001, 42: 533 -
4f
Voznyi IV.Novikov MS.Khlebnikov AF.Kopf J.Kostikov RR. J. Chem. Soc., Perkin Trans. 1 2002, 1628 -
4g
Novikov MS.Khlebnikov AF.Shevchenko MV. J. Fluorine Chem. 2003, 123: 177 -
4h
Khlebnikov AF.Novikov M.Amer AA. Tetrahedron Lett. 2002, 43: 8523 -
5a
Khlebnikov AF.Novikov MS.Kostikov RR. Adv. Heterocycl. Chem. 1996, 65: 93 -
5b
Novikov MS.Khlebnikov AF.Masalev AE.Kostikov RR. Tetrahedron Lett. 1997, 38: 4187 -
5c
Novikov MS.Khlebnikov AF.Sidorina ES.Masalev AE.Kopf J.Kostikov RR. Russ. J. Org. Chem. 2002, 38: 672 -
5d
Novikov MS.Khlebnikov AF.Kostikov RR. Russ. J. Org. Chem. 2002, 38: 1647 -
6a
McCarthy JR.Barney CL.O’Donnell MJ.Huffman JC. J. Chem. Soc., Chem. Commun. 1987, 469 -
6b
Khlebnikov AF.Novikov MS.Kostikov RR. Mendeleev Commun. 1997, 145 -
7a
Berg-Nielson K. Acta Chem. Scand., Ser. B 1977, B31: 224 -
7b
Khlebnikov AF.Kostik EI.Kostikov RR. Chem. Heterocycl. Compd. 1991, 636 -
7c
Romashin YN.Liu MTH.Nijjar SS.Attanasi OA. Chem. Commun. 2000, 1147 -
7d
Bonneaua R.Romashin YN.Liu MTH. J. Photochem. Photobiol., A 1999, 126: 31 -
7e
Bonneau R.Romashin YN.Liu MTH.MacPherson SE. J. Chem. Soc., Chem. Commun. 1994, 509 -
7f
Liu MTH.Romashin YN.Bonneau R. Int. J. Chem. Kin. 1994, 26: 1179 -
8a
Romashin YN.Liu MTH.Bonneau R. Chem. Commun. 1999, 447 -
8b
Romashin YN.Liu MTH.Ma W.Moss RA. Tetrahedron Lett. 1999, 40: 7163 -
9a
Taylor EC.Turchi IJ. Chem. Rev. 1979, 79: 181 -
9b
Baldwin JE.Pudussery RG.Qureshi AK.Sklarz B. J. Am. Chem. Soc. 1968, 90: 5325 - 10
Pinter A.Nyerges M.Viranyi A.Töke L. Tetrahedron Lett. 2003, 44: 2345
References
General Procedure for Preparation of Compounds 3 and 4.
A flask containing active lead (1.2 g, 5.8 mmol) and CH2Cl2 (7 mL) was charged with Bu4NBr (2.0 g, 6.0 mmol), imine 1a-f (2.7 mmol), and CBr2F2 (1.95 g, 9.3 mmol). The flask was tightly stopped, and the mixture was irradiated with ultrasound at 40 °C until the lead was completely consumed. Chromatography (hexane-EtOAc, 4:1) followed by recrystallization provided compounds 4 or/and 3.
5-(4-Bromophenyl)-4,4,6,6-tetrafluoro-2-(2-fluoro-phenyl)-4,5,5a,6-tetrahydro-3a
H
-cyclo-propa[
b
]fu-ro[2,3-
c
]pyrrole (
3d): mp 135-140 °C dec. (hexane-Et2O). 1H NMR (300 MHz, CDCl3): δ = 3.88 (t, J
HF = 7.3 Hz, 1 H, 5a-H), 4.60 (dddd, J = 13.3, 6.4, 3.9, 2.6 Hz, 1 H, 3a-H), 5.93 (dd, J = 3.9, 2.6 Hz, 1 H, 3-H), 7.01-7.69 (m, 8 H, Ar-H). 13C NMR (75 MHz, CDCl3): δ = 50.5 (t, J
CF = 15.5 Hz, 1a-C), 58.4 (t, J
CF = 32.1 Hz, 3a-C), 70.0 (m, 6a-C), 98.0 (d, J
CF = 14.4 Hz, 3-C), 109.7 (ddd, J
CF = 320, 302, 9.4 Hz, 6-C), 115.3, 115.6 (d, J
CF = 21.6 Hz), 116.6 (d, J
CF = 11.6 Hz), 118.4, 123.9 (d, J
CF = 3.9 Hz), 127.3 (d, J
CF = 1.7 Hz, CAr), 128.6 (ddd, J
CF = 260, 247, 5.5 Hz, 4-C), 130.9 (d, J
CF = 8.8 Hz), 131.8, 137.7 (d, J
CF = 5.0 Hz, CAr), 152.7 (2-C), 159.9 (d, J
CF = 254 Hz, CAr-F). Anal. Calcd for C19H11BrF5NO: C, 51.38; H, 2.50; N 3.15. Found: C, 51.41; H, 2.75; N, 2.92.
6,6-Difluoro-5-phenyl-5a,6-dihydro-3a
H
-cyclo-propa[
b
]furo[2,3-
c
]pyrrol-4 (5
H
)-one (
4a): mp 87-88 °C (hexane-Et2O). IR (CHCl3): 1725 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 3.96 (dd, 3
J HF = 8.2, 1.7 Hz, 1 H, 5a-H), 4.22 (dd, J = 4.5, 2.6 Hz, 1 H, 3a-H), 5.54 (dd, J = 4.5, 2.6 Hz, 1 H, 3-H), 6.62 (t, J = 2.6 Hz, 1 H, 2-H), 7.23-7.54 (m, 5 H, Ph-H). 13C NMR (75 MHz, CDCl3): δ = 49.5 (dd, J
CF = 17.7, 15.5 Hz, 5a-C), 51.6 (d, J
CF = 1.7 Hz, 3a-C), 68.2 (dd, J
CF = 19.4, 11.1 Hz, 6a-C), 100.4 (d, J
CF = 1.1 Hz, 3-C), 108.5 (dd, J
CF = 319, 301 Hz, 6-C), 120.7, 125.7, 128.8, 137.3 (CPh), 147.5 (2-C), 170.8 (dd, J
CF = 3.9, 3.2 Hz, 4-C). Anal. Calcd for C13H9F2NO2: C, 62.65; H, 3.64; N, 5.62. Found: C, 62.64; H, 3.82, N, 5.73.
General Procedure for Preparation of Compounds 8.
Compound 3 or 4 (0.52 mmol) is placed to a dry, 10 mL, one-necked round-bottomed flask and is heated at 160 °C for 10 min. Upon cooling to r.t. a brown solid forms; recrystallization from CH2Cl2-Et2O mixture gives furo[3,2-c]pyridine 8 as a colorless solid.
7-Fluoro-5-phenylfuro[3,2-
c
]pyridine-4 (5
H
)-one (
8a): mp 120-121 °C (CH2Cl2-Et2O). IR (CHCl3): 1630 (C=C), 1705 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.07 (dd, J
HH = 2.0 Hz, J
HF = 2.3 Hz, 1 H, 3-H), 7.28 (d, J
HF = 5.9 Hz, 1 H, 6-H), 7.39-7.52 (m, 5 H, Ar-H), 7.63 (d, 1 H, J
HH = 2.0 Hz, 2-H). 13C NMR (75 MHz, CDCl3): δ = 108.2 (d, J
CF = 2.2 Hz, 3-C), 117.5 (d, J
CF = 3.3 Hz, 3a-C), 119.7 (d, J
CF = 32.6 Hz, 6-C), 126.5, 128.1, 129.0 (CAr), 137.8 (d, J
CF = 239 Hz, 7-C), 140.0 (CAr), 144.6 (2-C), 148.9 (d, J
CF = 15.5 Hz, 7a-C), 156.9 (4-C). Anal. Calcd for C13H8FNO2: C, 68.12; H, 3.52; N 6.11. Found: C, 67.96; H, 3.55; N 6.08.